Abstract:Abstract Improving cancer patients Overall Survival (OS) prognosis is critical for personalization of treatment using model-identified drivers of cancer progression. Current cancer prognosis models largely rely on clinical and demographic patient characteristics. Adding ‘omics’-based modalities can help improve patient OS prediction and lead to better disease categorization and understanding. We introduce a data driven methodology for combining multi-omics and clinical data, including clinical/demographics, mutations, gene expression, long non-coding and micro-RNA expression, DNA methylation, and proteomics for improving prediction of OS in cancer patients. High dimensionality of ‘omics’ modalities present challenges to combining them into one model. We propose a late stage modalities fusion where we construct a separate data driven model for OS prediction for each modality, later combining individual predictions in a final linear OS prediction model. With a limited number of patients to develop the model, such an approach helps to better protect against overfitting, and allows to account for different degrees of informativeness of modalities by weighting them according to individual success. We introduce a robust machine learning pipeline with rigorous training, testing and evaluation capabilities, and demonstrate its effectiveness on a suit of TCGA data. When comparing early vs. late fusion of omics and clinical modalities for survival prediction using NSCLC TCGA data, we observe the C-index improvement from 0.57±.04 to 0.61±.01. Best individual modality performance was at 0.59±.02 using clinical modality. Dominant modalities in unimodal survival analysis varied between cancers, with clinical, RNA, and miRNA for LUAD, and clinical, RNA, and RPPA for LUSC. Using pan-cancer TCGA data for survival prediction, the best C-index = 0.77 was achieved using multi-omics model, followed by 0.76±.01 for clinical, 0.75±.01 for RNA seq, and 0.73±.01 for RPPA unimodal models. Citation Format: Nikos Nikolaou, Domingo Salazar, Harish RaviPrakash, Miguel Goncalves, Gustavo Alonso Arango Argoty, Nikolay Burlutsky, Natasha Markuzon, Etai Jacob. Improving survival prediction using flexible late fusion machine learning framework for multi-omics data integration. [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2023; Part 1 (Regular and Invited Abstracts); 2023 Apr 14-19; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2023;83(7_Suppl):Abstract nr 5395.

Multi-omics fusion analysis models with machine learning predict survival of HER2-negative metastatic breast cancer: a multicenter prospective observational study

Multi-omics with Dynamic Network Biomarker Algorithm Prefigures Organ-Specific Metastasis of Lung Adenocarcinoma

A longitudinal circulating tumor DNA-based model associated with survival in metastatic non-small-cell lung cancer

Quantifying the advantage of multimodal data fusion for survival prediction in cancer patients

Machine learning applications in breast cancer survival and therapeutic outcome prediction based on multi-omic analysis

Deep learning based feature-level integration of multi-omics data for breast cancer patients survival analysis

Improving Prediction of Survival and Progression in Metastatic Non-Small Cell Lung Cancer After Immunotherapy Through Machine Learning of Circulating Tumor DNA

Machine learning-informed liquid-liquid phase separation for personalized breast cancer treatment assessment

Abstract 5395: Improving survival prediction using flexible late fusion machine learning framework for multi-omics data integration

SurvivalML: an Integrative Platform for the Discovery and Exploration of Prognostic Models in Multi-Center Cancer Cohorts

Toward Precision Breast Cancer Survival Prediction Utilizing Combined Whole Genome-Wide Expression and Somatic Mutation Analysis

Improving Prediction of Survival and Progression in Metastatic Non-Small Cell Lung Cancer Following Immunotherapy Through Machine Learning of Circulating Tumor DNA Dynamics

Single-cell omics and machine learning integration to develop a polyamine metabolism-based risk score model in breast cancer patients

Enhancing Breast Cancer Survival Prognosis Through Omic and Non-Omic Data Integration

Multi-omics analysis reveals a molecular landscape of the early recurrence and early metastasis in pan-cancer

Integrating Somatic Mutations for Breast Cancer Survival Prediction Using Machine Learning Methods

Development of Omics Data Based Survival Models for Four Female Cancers Using Machine Learning Approaches

Predicting recurrence and metastasis risk of endometrial carcinoma via prognostic signatures identified from multi-omics data

Predicting gastric cancer response to anti-HER2 therapy or anti-HER2 combined immunotherapy based on multi-modal data

Pancancer survival prediction using a deep learning architecture with multimodal representation and integration

A multimodal ensemble approach for clear cell renal cell carcinoma treatment outcome prediction